The Journal of Clinical Psychiatry

Page 340

More JCP Articles

Article

First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder.

April 15, 2009

Jonathan R. T. Davidson

Article

Refractory Generalized Anxiety Disorder

April 15, 2009

Mark H. Pollack

Original Research

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

April 7, 2009

Michael R. Liebowitz , Gregory Asnis , Richard Mangano , et al

Original Research

Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study

April 7, 2009

Marina D. Díaz-Marsá , Sara Sánchez , Fernando Rico-Villademoros

Original Research

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

April 7, 2009

Michael Bauer , Herman W. Pretorius , Eric L. Constant , et al

Original Research

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

April 7, 2009

Andrew J. Cutler , Stuart A. Montgomery , David Feifel , et al

Original Research

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

April 7, 2009

Lori L. Altshuler , Robert M. Post , Gerhard Hellemann , et al

Original Research

Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study

April 7, 2009

Nilufar Mossaheb , Silvia Weissgram , Sonja Zehetmayer , et al

Original Research

Length of Time Between Onset of Childhood Sexual Abuse and Emergence of Depression in a Young Adult Sample: A Retrospective Clinical Report

April 7, 2009

Martin H. Teicher , Jacqueline A. Samson , Ann Polcari , et al

Original Research

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

April 7, 2009

Deanna L. Kelly , Robert W. Buchanan , Douglas L. Boggs , et al

Original Research

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

April 7, 2009

John W. Newcomer , Robert E. Ratner , Jan W. Eriksson , et al

Article

Mild Behavioral Impairment and Risk of Dementia: A Prospective Cohort Study of 358 Patients

March 24, 2009

Fernando E. Taragano , Ricardo F. Allegri , Hugo Krupitzki , et al

« 1 … 338 339 340 341 342 … 757 »

First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder.

Refractory Generalized Anxiety Disorder

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study

Length of Time Between Onset of Childhood Sexual Abuse and Emergence of Depression in a Young Adult Sample: A Retrospective Clinical Report

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

Mild Behavioral Impairment and Risk of Dementia: A Prospective Cohort Study of 358 Patients

ELSEWHERE:

FOLLOW US:

More JCP Articles

First-Line Pharmacotherapy Approaches for Generalized Anxiety Disorder.

Refractory Generalized Anxiety Disorder

A Double-Blind, Placebo-Controlled, Parallel-Group, Flexible-Dose Study of Venlafaxine Extended Release Capsules in Adult Outpatients With Panic Disorder

Effectiveness and Tolerability of Oral Ziprasidone in Psychiatric Inpatients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder: A Multicenter, Prospective, and Naturalistic Study

Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder: Results of a Randomized, Placebo-Controlled, Double-Blind Study

Extended Release Quetiapine Fumarate Monotherapy in Major Depressive Disorder: A Placebo- and Duloxetine-Controlled Study

Impact of Antidepressant Continuation After Acute Positive or Partial Treatment Response for Bipolar Depression: A Blinded, Randomized Study

Late-Onset Depression in Elderly Subjects From the Vienna Transdanube Aging (VITA) Study

Length of Time Between Onset of Childhood Sexual Abuse and Emergence of Depression in a Young Adult Sample: A Retrospective Clinical Report

A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia

A 24-Week, Multicenter, Open-Label, Randomized Study to Compare Changes in Glucose Metabolism in Patients With Schizophrenia Receiving Treatment With Olanzapine, Quetiapine, or Risperidone

Mild Behavioral Impairment and Risk of Dementia: A Prospective Cohort Study of 358 Patients

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles